賽爾生物人類科技有限公司 - 資產負債表 (Quarterly)

賽爾生物人類科技有限公司
KR ˙ KOSDAQ
₩5,390.00 ↓ -70.00 (-1.28%)
2026-06-05
分享價格
資產負債表 (Quarterly)

賽爾生物人類科技有限公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
12-31
2022
06-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 13,929 4,881 4,495 2,114 5,189 2,720 4,052 2,462 4,087 2,504 3,099 3,273 7,226 10,825 15,917 18,703
改變 (%) -64.96 -7.91 -52.96 145.44 -47.59 49.00 -39.24 65.98 -38.72 23.76 5.60 120.78 49.80 47.04 17.50
流動資產 32,071 16,663 19,936 20,978 27,610 27,197 26,918 26,957 25,863 25,860 23,992 25,685 25,586 30,870 44,021 45,929
改變 (%) -48.04 19.64 5.23 31.61 -1.50 -1.03 0.14 -4.06 -0.01 -7.22 7.05 -0.39 20.65 42.60 4.34
資產 58,069 42,809 45,982 47,174 53,553 53,152 53,196 52,862 52,353 52,856 52,905 55,499 54,301 64,134 88,458 90,411
改變 (%) -26.28 7.41 2.59 13.52 -0.75 0.08 -0.63 -0.96 0.96 0.09 4.90 -2.16 18.11 37.93 2.21
負債 19,342 7,726 7,877 14,711 9,519 7,736 8,634 7,943 8,222 7,711 6,493 8,144 7,366 12,051 29,455 29,197
改變 (%) -60.06 1.95 86.75 -35.29 -18.73 11.60 -8.00 3.52 -6.22 -15.79 25.42 -9.55 63.61 144.41 -0.87
公平 38,726 35,083 38,105 32,464 44,034 45,416 44,563 44,919 44,131 45,145 46,412 47,355 46,935 52,083 59,003 61,214
改變 (%) -9.41 8.61 -14.80 35.64 3.14 -1.88 0.80 -1.76 2.30 2.81 2.03 -0.89 10.97 13.29 3.75
負債和股本 58,069 42,809 45,982 47,174 53,553 53,152 53,196 52,862 52,353 52,856 52,905 55,499 54,301 64,134 88,458 90,411
改變 (%) -26.28 7.41 2.59 13.52 -0.75 0.08 -0.63 -0.96 0.96 0.09 4.90 -2.16 18.11 37.93 2.21

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista